Sylvain Querol (MEng), tendering manager, Europe, at Powder Systems Limited on how to achieve high containment for HPAPI small-scale production.

Over 25% of the total drugs produced worldwide are being classified as highly potent. The High Potency Active Pharmaceutical Ingredient (HPAPI) market is rapidly growing creating new opportunities in a competitive landscape. Process technology providers need to keep up with stringent regulations to meet the market demand for high containment solutions.

For more information click here.

To read the full article click here.